Announcements

Job offersmore »



Tweeting Growers

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Exchange ratesmore »




US: Cannabis Science CEO to speak at Harvard Medical School

Cannabis Science's President, CEO and Co-Founder, Raymond C. Dabney, will be a keynote speaker and panelist at the Global Health Catalyst (GHC) Summit at Harvard Medical School on April 28-30, 2017. Additionally, Cannabis Science's Chief Medical Officer (CMO), Allen Herman, will Co-Chair a special session at the GHC Summit. Both Dabney and Herman previously presented at Harvard Medical School in November 2016.

Dabney will be the keynote speaker and a panelist for a special session on "Cannabis Science Versus Cancer and Other Malignancies." Dabney will discuss how cannabinoids can be used to treat cancer and other diseases, manage the side effects of cancer treatment like radiotherapy and chemotherapy, and potential applications of medical cannabis in global health to close the global pain divide; Cannabis Science's vision for the global health and development impact of cannabinoid-based medicines; and the need for greater public education on the importance of medical cannabis research.

Additionally, Dabney will present summit participants with an overview of the company's current drug development program, as well as with an update on Cannabis Science's Collaborative Research Agreement (CRA) with Dana-Farber Cancer Institute (Dana-Farber). In addition to co-chairing the session, Herman will participate in the discussion on the epidemiology of cancer and the utilization of opioids in Africa as opioid utilization rates reflect the pain divide. This conference affords Cannabis Science an opportunity to discuss cutting-edge cannabinoid research with some of the greatest minds in modern medicine globally, as well as to network and explore potential partnerships. In addition, through participation in this Summit, Cannabis Science will give updates on progress in the implementation of Cannabis Science's research agreement with Dana-Farber and a potential consortium agreement involving other institutions.

On January 3, 2017, Cannabis Science entered into a CRA with Dana-Farber, one of the world's leading cancer centers. Under the terms of the CRA, Cannabis Science and Dana-Farber will jointly investigate and develop use of cannabinoids to treat various forms of cancers.

"I am excited about Cannabis Science's relationship with Dana-Farber. When I first met Wilfred Ngwa, PhD, Director of Global Health Catalyst at Harvard Medical School and Principal Investigator for the CRA, we immediately realized potential synergies on cancer research interests, and the potential to collaborate to develop cannabinoid-based medicines to treat cancer and control cancer symptoms with minimal side-effects," stated Dabney.

Dabney and Ngwa met during the Constituency for Africa's (CFA) annual Ronald H. Brown African Affairs Series in Washington, DC in September 2016, where they both were on the speaking program. Mr. Dabney is a Member of the Board of Directors of CFA, and the Vice Chairman of CFA's African Healthcare Infrastructure Committee (AHIC).

For more information:
www.globalhealthcatalystsummit.org
cannabisscience.com

Publication date: 3/8/2017

 


 

Other news in this sector:

10/17/2017 Will legalized marijuana give a new impulse to Mexico's economy?
10/17/2017 Medicinal marijuana one step away from legalization in Peru
10/17/2017 US (MI): Marijuana degree combines science and business
10/16/2017 Macedonian MMJ grower invests in Heliospectra LEDs
10/16/2017 What is Vapor Pressure Deficit and why does it matter?
10/16/2017 Cronos announces distribution agreement in Germany
10/13/2017 US (NV): Marapharm building third facility in Las Vegas
10/13/2017 Canada: Namaste and Authenticating.com partner in MJ identity verification
10/12/2017 Hydropothecary CEO on competing with the marijuana black market
10/12/2017 Puerto Rico MMJ businesses assess hurricane damage
10/12/2017 CAN (BC): Joint venture converts 1.3 million sq. ft. into MMJ greenhouses
10/11/2017 CAN (ON): Canntrust receives cultivation license for Niagara facility
10/10/2017 US (CA): Bob Echter speaks up for marijuana cultivation
10/10/2017 CAN (ON): Supreme crosses important revenue milestone
10/9/2017 CAN (QC): Hydropothecary wins job creation award
10/9/2017 CAN (ON): Construction in full swing at 7ACRES
10/9/2017 US: FDA hints it may look into marijuana health claims
10/9/2017 CAN (ON): Scientus Pharma gets permission to grow MMJ
10/5/2017 Canada: Trudeau proposes tax on marijuana
10/5/2017 CAN (ON): Supreme to quadruple capacity at 7ACRES hybrid facility